Luzon, Mary Ann A.

HRN: 22-30-49  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/25/2022
CEFUROXIME 1.5GM (VIAL)
12/26/2022
12/27/2022
IV
1.5
Single
LTCS
Waiting Final Action 
12/26/2022
CEFUROXIME 1.5GM (VIAL)
12/26/2022
12/27/2022
IVT
1.5g
Q8 X 2 Doses
S/P Repeat LTCS
Waiting Final Action 
12/27/2022
CEFUROXIME 500MG (TAB)
12/27/2022
01/02/2023
PO
500
BID
Repeat LSCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: